|
Characteristics
|
N = 36
|
|---|
|
Median Age yrs. (IQR)
|
59 (42, 65)
|
|
Sex (female)
|
25 (69)
|
|
Insurer
|
|
Medicare
|
6 (17)
|
|
Medicaid
|
21 (58)
|
|
Medicare/Medicaid
|
5 (72)
|
|
Commercial
|
4 (11)
|
|
Current PPI
|
|
Omeprazole
|
28 (78)
|
|
Pantoprazole
|
5 (14)
|
|
Esomeprazole
|
1 (3)
|
|
Lansoprazole
|
2 (6)
|
|
Dose level
|
|
Low
|
0 (0)
|
|
Standard
|
22 (61)
|
|
High
|
14 (39)
|
|
Median length of PPI use, days (IQR)
|
1160 (367, 1671)
|
|
Median medications (IQR)
|
17 (11, 32)
|
|
Median co-morbidities (IQR)
|
20 (13, 27)
|
|
Selected Co-morbidities
|
|
Nutrient deficiencies
|
8 (22)
|
|
Tobacco dependence
|
11 (31)
|
|
Obesity
|
14 (39)
|
|
Mental Health
|
24 (67)
|
|
Indications
|
|
GERD or heartburn diagnosis
|
18 (50)
|
|
No indication found
|
12 (33)
|
- aData are n (%) unless otherwise indicated. IQR Interquartile Range
